LASMA Tablets
| Ø |
LASMA is Montelukast sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT, receptor. |
| Ø |
LASMA is widely accepted drug for Asthma because of its safety profile. It can be used as add-on therapy to inhaled corticosteroid in moderate to severe asthma |
Composition
LASMA 4
Each chewable tablet contains
Montelukast sodium(equivalent to Montelukast) 4 mg |
LASMA 5
Each chewable tablet ontains
Montelukast sodium(equivalent to Montelukast) 5 mg |
|
|
LASMA 10
Each film-coated tablet contains
Montelukast sodium(equivalent to Montelukast) 10 mg |
|
Dosage and administration
- Adolescents and adults 15 years of Age and older: One LASMA 10 tablet daily to be taken in the evening.
- Pediatric patients 6 to 14 years of age: One LASMA 5 chewable tablet daily to be taken in the evening.
- Pediatric patients 2 to 5 years of age: One LASMA 4 chewable tablet daily to be taken in the evening.
Indications
| Ø |
Mild persistent asthma |
| Ø |
As add-on therapy to inhaled corticosteroid in moderate to severe asthma |
| Ø |
Co-existing allergic rhinitis in asthma |
Presentation
10 X 10 strips of LASMA 10 film coated tablets
10 X 10 strips of LASMA 5 chewable tablets
10 X 10 strips of LASMA 4 chewable tablets |
